PPD completes Evidera acquisition, committed to seamless integration

By Melissa Fassbender

- Last updated on GMT

Evidera’s real world research services will further strengthen PPD’s peri- and post-approval capabilities. (Image: iStock/Nastco)
Evidera’s real world research services will further strengthen PPD’s peri- and post-approval capabilities. (Image: iStock/Nastco)

Related tags Subsidiary

Pharmaceutical Product Development, LLC (PPD), has announced the completed acquisition of Evidera as the two companies commit to making the “seamless offering a reality.”

As Outsourcing-Pharma.com previously reported, the contract research organization (CRO) announced the acquisition​ in August of this year, citing the growing need for real-world data.

Jon Williams, president of Evidera, told us the closing the acquisition went smoothly, taking less than four weeks from signing.

We’re aligning the PPD and Evidera teams to uncover opportunities to more effectively generate, interpret and communicate real-world evidence on behalf of our clients​,” he added.

Together, Williams said PPD and Evidera will deliver “comprehensive development strategies​” that will help its clients earn regulatory approval and generate the real-world evidence needed for pricing and reimbursement discussions, as well as for optimized market access. 

Over the coming weeks and months we will create the necessary points of connection and operational processes to make this seamless offering a reality​,” Williams explained.

Evidera will operate as a wholly owned subsidiary of PPD, though Williams said the newly combined company will maintain Evidera’s culture and focus on scientific excellence and thought leadership in real-world research, “while also working very closely with our new parent company​,” he explained.

We expect that PPD’s world-class global operations and regulatory expertise combined with our unparalleled capabilities in the late phase and market access space will not only be a unique asset, but will serve as a unifying force that will bring the two companies together to offer a powerful set of solutions​,” added Williams.

Above all, we are committed to achieving a seamless integration with no loss of focus on innovation, industry leadership and client service​.”

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us

Products

View more

Webinars